A Phase 1 interventional study of Galvanic vestibular stimulation and MovAlyzeR® software from Neuroscript in Cortical Excitability and Multiple Sclerosis, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2024-01-08.
Sponsored by Cairo University · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Multiple Sclerosis by Cairo University — 8 open to participants now, 10 under way, none of them phase 3. Multiple Sclerosis · Cairo University.
Among the 26 studies in Multiple Sclerosis by Cairo University, this one is the 10th largest by planned enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2023, is the only one in phase 1, and was the 11th registered.
3,273 studies on the registry are indexed under Multiple Sclerosis; 665 are open to participants now.
Browse Multiple Sclerosis studies →8 of the 26 studies in Multiple Sclerosis by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 20–35
Cairo University · Sites in Egypt
Ages 20–50
Cairo University
Ages 20–40
Cairo University
Ages 25–40
Cairo University · Sites in Egypt
Ages 20–50
By country, each count listing its studies:
Of the 434 Multiple Sclerosis studies recruiting now, 164 (38%) set no upper age limit and 214 (49%) stop at 75 or younger; 40 take children under 18; 95 take healthy volunteers.
This study: 20 Years to 45 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 3 started in 2023.
This study's planned enrollment of 40 is below the median of 50 across 2,208 interventional studies indexed under Multiple Sclerosis.
Median enrollment 40 across the 20 interventional studies, 265 across the 6 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
3 of the studies in Multiple Sclerosis by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07943247Cairo UniversityCorrelation Between Physical Activity and Pulmonary Endurance in MS Patients | 2027-02-01 |
| NCT07918339Cairo UniversityVirtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis | 2027-03-15 |
| NCT07762326Cairo UniversityEffect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis | 2027-03-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 26 studies in Multiple Sclerosis by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will be conducted to investigate the following:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will be excluded if they have:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Galvanic Vestibular Stimulation in addition to the Conventional Physical Therapy program of moderate intensity aerobic training on cyclic ergometer for upper limb and task oriented training for hand dexterity.
Device: Galvanic vestibular stimulation · Device: MovAlyzeR® software from Neuroscript · Device: BODYFIT Mini Portable Pedal Home Exerciser (cyclic ergometer)
Conventional Physical Therapy program of moderate intensity aerobic training on cyclic ergometer for upper limb and task oriented training for hand dexterity.
Device: MovAlyzeR® software from Neuroscript · Device: BODYFIT Mini Portable Pedal Home Exerciser (cyclic ergometer)
galvanic current generated by Gymna DUO 200 and delivered through conductive medium (electrode gel) by two small carbon rubber electrodes 3 cm 2 each bilaterally over two mastoid processes for 30 minutes, two times per week for 12 weeks .
MovAlyzeR® movement analysis software from Neuroscript turns a pen tablet or mouse into a high-quality system for examining movements by a pen, mouse or finger. Hence, it can train and analyze hand dexterity and handwriting using pen tablets such as sentence parameters.
stationary upper body pedaling as a moderate intensity aerobic training
Cortical changes
central motor conduction time is the time taken for neural impulses to travel through the central nervous system on their way to the target muscles.
Time frame: 15 minutes
Upper Limb motor dexterity
Nine hole peg test 9 HPT
Time frame: 15-20 minutes
Advanced dexterity (Handwriting analysis) by MovAlyzeR® software
Time frame: 15-20 minutes
Balance
Berg Balance scale (BBS) of 14 items graded on 5 scoring system 0= worst and 4= the best ( total 0 = worst performance - Total 56 = Best performance). The lower your score, the more at risk you are for losing your balance. In general, Berg balance scale scores are interpreted as such: 0 to 20: A person with a score in this range will likely need the assistance of a wheelchair to move around safely.
Time frame: 15-20 minutes
Fatigue
Fatigue Severity Scale (FSS)is 9-item questionnaire, scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree. The minimum score = 9 and maximum score possible = 63. Higher the score = greater fatigue severity.
Time frame: 15-20 minutes
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2023 (actual). Primary completion is estimated for Dec 2024, 15 months after the start.
Of 53 non-industry phase 1 interventional studies under Multiple Sclerosis, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 71. This study's planned 15 months is below that.
Counting every sponsor, half of 92 studies reached it within 30 months; a quarter within 9 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.